Literatur
- 1
Sporer K A, Khayam-Bashi H.
Acetaminophen and Salicylate Serum Levels in Patients With Suicidal Ingestion or Altered
Mental Status.
Am J Emerg Med.
1996;
14 (5)
443-446
- 2
Kostrubsky V E. et al .
Role of CYP3A in Ethanol-mediated increases in acetaminophen hepatotoxicity.
Toxicol Appl Pharmacol.
1997;
143 (2)
315-323
- 3 Ellenhorn M J, Barceloux D G. Medical toxicology. New York, Amsterdam, London; Elsevier
1988
- 4
Smilkstein M J. et al .
Acetaminophen overdose: A 48-hour intravenous N-acetylcysteine treatment protocol.
Ann Emerg Med.
1991;
20
1058-1063
- 5
Alistair M. et al .
A 7 year experience of severe acetaminophen-induced hepatoxicity.
Gastroenterology.
1995;
109
1907-1916
- 6
O'Grady J, Alexander G, Hayllar K, Williams R.
Early indicators of prognosis in fulminant hepatic failure.
Gastroenterology.
1989;
97
439-445
- 7
Bernal W, Donaldson N, Wyncoll D, Wendon J.
Blood lactate as an early predictor of outcome in paracetamol-induced acute liver
failure: a cohort study.
Lancet.
2002;
359
558-563
- 8
Schmidt L E, Dalhoff K.
Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity.
Hepatology.
2002;
36 (3)
659-665
Priv.-Doz. Dr. Frank Martens
Charité -Universitätsmedizin Berlin, Campus Virchow Klinikum · Klinik für Nephrologie
und internistische Intensivmedizin
Augustenburger Platz 1
13353 Berlin
Email: frank.martens@charite.de
